- Puma Biotechnology to Join Russell 3000 Index
- Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting
- Puma Biotechnology Reports First Quarter Financial Results
- Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
- Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results
More ▼
Key statistics
On Tuesday, Puma Biotechnology Inc (PBYI:NSQ) closed at 4.02, 88.73% above the 52 week low of 2.13 set on Oct 25, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.00 |
---|---|
High | 4.03 |
Low | 3.93 |
Bid | 1.61 |
Offer | 4.92 |
Previous close | 4.02 |
Average volume | 582.97k |
---|---|
Shares outstanding | 48.24m |
Free float | 40.81m |
P/E (TTM) | 12.49 |
Market cap | 193.92m USD |
EPS (TTM) | 0.3219 USD |
Data delayed at least 15 minutes, as of May 28 2024 21:00 BST.
More ▼